首页 正文

Review Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2020 Oct;17(4):1563-1581. doi: 10.1007/s13311-020-00888-5 Q16.92025

Four-Repeat Tauopathies: Current Management and Future Treatments

四元tau蛋白病的当前管理和未来治疗 翻译改进

Lawren VandeVrede  1, Peter A Ljubenkov  2, Julio C Rojas  2, Ariane E Welch  2, Adam L Boxer  2

作者单位 +展开

作者单位

  • 1 Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA. Lawren.VandeVrede@ucsf.edu.
  • 2 Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
  • DOI: 10.1007/s13311-020-00888-5 PMID: 32676851

    摘要 Ai翻译

    Four-repeat tauopathies are a neurodegenerative disease characterized by brain parenchymal accumulation of a specific isoform of the protein tau, which gives rise to a wide breadth of clinical syndromes encompassing diverse symptomatology, with the most common syndromes being progressive supranuclear palsy-Richardson's and corticobasal syndrome. Despite the lack of effective disease-modifying therapies, targeted treatment of symptoms can improve quality of... ...点击完成人机验证后继续浏览
    Copyright © Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Neurotherapeutics

    缩写:NEUROTHERAPEUTICS

    ISSN:1933-7213

    e-ISSN:1878-7479

    IF/分区:6.9/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Four-Repeat Tauopathies: Current Management and Future Treatments